Irene Kuehrer

405 total citations
20 papers, 319 citations indexed

About

Irene Kuehrer is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Irene Kuehrer has authored 20 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 7 papers in Molecular Biology and 6 papers in Cancer Research. Recurrent topics in Irene Kuehrer's work include Pancreatic and Hepatic Oncology Research (7 papers), Cancer Genomics and Diagnostics (6 papers) and Colorectal Cancer Treatments and Studies (6 papers). Irene Kuehrer is often cited by papers focused on Pancreatic and Hepatic Oncology Research (7 papers), Cancer Genomics and Diagnostics (6 papers) and Colorectal Cancer Treatments and Studies (6 papers). Irene Kuehrer collaborates with scholars based in Austria, Italy and Czechia. Irene Kuehrer's co-authors include Michael Gnant, Klaus Sahora, Christine Brostjan, Sebastian F. Schoppmann, Peter Goetzinger, Patrick Starlinger, Dominic Schauer, P. C. Brugger, Martin Schindl and R. Jakesz and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Thrombosis and Haemostasis and World Journal of Surgery.

In The Last Decade

Irene Kuehrer

18 papers receiving 313 citations

Peers

Irene Kuehrer

ONCOL

CR

SURGE

EPIDE

PRM

Keum Ha Choi South Korea

Lea Latham Italy

Jamil Asselah Canada

Arzu Oğuz Türkiye

Shinichi Asaka Japan

Yiming Zhao China

Keiichi Akahoshi Japan

Tetsuya Urasaki Japan

Shuichi Tsukamoto Japan

Liusheng Wu China

Keum Ha Choi South Korea

Irene Kuehrer

134 ×0.7

ONCOL

112 ×1.2

CR

107 ×1.2

SURGE

89 ×1.0

EPIDE

122 ×1.5

PRM

Citations per year, relative to Irene Kuehrer Irene Kuehrer (= 1×) peers Keum Ha Choi

Countries citing papers authored by Irene Kuehrer

Since Specialization

Citations

This map shows the geographic impact of Irene Kuehrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irene Kuehrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irene Kuehrer more than expected).

Fields of papers citing papers by Irene Kuehrer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irene Kuehrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irene Kuehrer. The network helps show where Irene Kuehrer may publish in the future.

Co-authorship network of co-authors of Irene Kuehrer

This figure shows the co-authorship network connecting the top 25 collaborators of Irene Kuehrer. A scholar is included among the top collaborators of Irene Kuehrer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irene Kuehrer. Irene Kuehrer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Hametner, Simon, Jutta Bergler‐Klein, Irene Kuehrer, et al.. (2025). Incidence and Immunopathology of Myositis in Rectal Cancer Patients Treated With Neoadjuvant Immune Checkpoint Inhibitors and Chemoradiotherapy: Findings From the CHINOREC Trial. MedComm. 6(7). e70275–e70275. 1 indexed citations

2.

Laengle, Johannes, Irene Kuehrer, Dietmar Pils, et al.. (2022). Interim analysis of neoadjuvant chemoradiotherapy with sequential ipilimumab and nivolumab in rectal cancer (CHINOREC): A prospective randomized, open-label, multicenter, phase II clinical trial.. Journal of Clinical Oncology. 40(16_suppl). e15604–e15604. 3 indexed citations

3.

Laengle, Johannes, Irene Kuehrer, Dietmar Pils, et al.. (2021). Neoadjuvant chemoradiotherapy with sequential ipilimumab and nivolumab in rectal cancer (CHINOREC): A prospective randomized, open-label, multicenter, phase II clinical trial.. Journal of Clinical Oncology. 39(15_suppl). TPS3623–TPS3623. 3 indexed citations

4.

Laengle, Johannes, Irene Kuehrer, Dietmar Pils, et al.. (2020). P08.04 Neoadjuvant chemoradiotherapy with sequential ipilimumab and nivolumab in rectal cancer (CHINOREC): a prospective randomized, open-label, multicenter, phase II clinical trial. A51.1–A51. 2 indexed citations

5.

Fuereder, Thorsten, Judith Stift, Irene Kuehrer, et al.. (2014). Response to GEMOX plus erlotinib in pancreatic cancer is associated with ERCC1 overexpression. European Journal of Clinical Investigation. 44(10). 958–964. 8 indexed citations

6.

Sahora, Klaus, Martin Schindl, Irene Kuehrer, et al.. (2014). A phase II trial of two durations of Bevacizumab added to neoadjuvant gemcitabine for borderline and locally advanced pancreatic cancer.. PubMed. 34(5). 2377–84. 17 indexed citations

7.

Sahora, Klaus, Martin Schindl, Irene Kuehrer, et al.. (2013). Gemcitabine-based neoadjuvant chemotherapy for locally advanced pancreatic cancer does not affect mortality and morbidity after pancreatic resection. European surgery. Supplement/European surgery. 45(3). 169–178. 1 indexed citations

8.

Starlinger, Patrick, P. C. Brugger, Dominic Schauer, et al.. (2011). Myelosuppression of Thrombocytes and Monocytes Is Associated with a Lack of Synergy between Chemotherapy and Anti-VEGF Treatment. Neoplasia. 13(5). 419–427. 15 indexed citations

9.

Starlinger, Patrick, P. C. Brugger, Christian Reiter, et al.. (2011). Discrimination between Circulating Endothelial Cells and Blood Cell Populations with Overlapping Phenotype Reveals Distinct Regulation and Predictive Potential in Cancer Therapy. Neoplasia. 13(10). 980–990. 15 indexed citations

10.

Starlinger, Patrick, Dominic Schauer, P. C. Brugger, et al.. (2011). Platelet-Stored Angiogenesis Factors: Clinical Monitoring Is Prone to Artifacts. Disease Markers. 31(2). 55–65. 35 indexed citations

11.

Sahora, Klaus, Irene Kuehrer, Martin Schindl, et al.. (2011). NeoGemTax: Gemcitabine and Docetaxel as Neoadjuvant Treatment for Locally Advanced Nonmetastasized Pancreatic Cancer. World Journal of Surgery. 35(7). 1580–1589. 42 indexed citations

12.

Starlinger, Patrick, Dominic Schauer, P. C. Brugger, et al.. (2011). Platelet-stored angiogenesis factors: clinical monitoring is prone to artifacts.. PubMed. 31(2). 55–65. 35 indexed citations

13.

Sahora, Klaus, Irene Kuehrer, Peter Goetzinger, et al.. (2010). NeoGemOx: Gemcitabine and oxaliplatin as neoadjuvant treatment for locally advanced, nonmetastasized pancreatic cancer. Surgery. 149(3). 311–320. 79 indexed citations

14.

Starlinger, Patrick, Herwig P. Moll, Alice Assinger, et al.. (2010). Thrombospondin‐1: a unique marker to identify in vitro platelet activation when monitoring in vivo processes. Journal of Thrombosis and Haemostasis. 8(8). 1809–1819. 49 indexed citations

15.

Kuehrer, Irene. (2006). Multimodal treatment of metastatic colorectal cancer. Acta chirurgica iugoslavica. 53(2). 51–55. 1 indexed citations

16.

Teleky, B., Judith Karner‐Hanusch, Irene Kuehrer, et al.. (2006). Straight and colonic J-pouch reconstruction after low anterior resection. Acta chirurgica iugoslavica. 53(2). 109–112. 3 indexed citations

17.

Gnant, Michael, Irene Kuehrer, B. Teleky, et al.. (2004). Effect of neoadjuvant chemotherapy with gemcitabine and docetaxel on 3-year survival and resection rate in previously unresectable locally advanced pancreatic cancer. Journal of Clinical Oncology. 22(14_suppl). 4234–4234. 1 indexed citations

18.

Gnant, Michael, Irene Kuehrer, B. Teleky, et al.. (2004). Effect of neoadjuvant chemotherapy with gemcitabine and docetaxel on 3-year survival and resection rate in previously unresectable locally advanced pancreatic cancer. Journal of Clinical Oncology. 22(14_suppl). 4234–4234. 4 indexed citations

19.

Scheithauer, Werner, E. Fritz, C. Zielinski, et al.. (1989). VMCP Chemotherapy With or Without Interferon-alpha-2 in Newly Diagnosed Patients With Multiple Myeloma. Oncology Research and Treatment. 12(1). 27–29. 3 indexed citations

20.

Scheithauer, Werner, Irene Kuehrer, C. Dittrich, et al.. (1988). Phase II trial of recombinant interferon alpha-2C in metastatic renal cell carcinoma.. PubMed. 1(2). 81–6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact